PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$27.13
+0.44%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$27.01
From 52W high−16.16%
Volume2.91M
Market cap$2.08B
P/E (TTM)28.0x
P/S (TTM)1.6x
Div yield—
Key dataSep 18, 2026
Open
$27.01
From 52W high
−16.16%
Volume
2.91M
Market cap
$2.08B
ValuationView details →
P/E (Fwd)
19.6x
EV/EBITDA
14.7x
P/E (TTM)
28.0x
RSI (14)
48.7
MomentumView details →
1D Return
+0.44%
YTD Return
+5.14%
SummaryUpdated Jun 1, 2026
Progyny, Inc. (NASDAQ:PGNY) is a specialized benefits management company founded in 2008 and headquartered in New York. Originally incorporated as Auxogyn, Inc., the company rebranded to Progyny in 2015 and went public in October 2019. Progyny has established itself as a leading provider of fertility and family building benefits solutions for employers across the United States, serving over 530 clients with approximately 6.7 million covered lives as of 2025.
Similar companies
Latest newsMore news →
Progyny reported Q2 CY2026 revenue of $350.5 million and adjusted EPS of $0.55, beating analyst estimates, but the stock fell in reaction.37d agoProgyny Inc's stock fell 4.6% to $26.55 on August 11, 2026.40d agoProgyny reported Q2 2026 adjusted earnings of $0.55 per share on revenue of $350.51 million, beating analyst estimates of $0.34 and $348.69 million, respectively.45d ago